According to GlobalData’s medical device pipeline database, five Extracellular Matrix Implants devices are in various stages of development globally. GlobalData’s report Extracellular Matrix Implants provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
All five devices of this category are in active stage of development. All devices are in the late stages of development.
Orthopedic devices are medical devices that are used to treat or prevent musculoskeletal disorders. Extracellular Matrix Implants are decellularized implants that match or mimic the 3D structure of cartilage and used to repair or replace damaged tissue. ECM is the natural material that surrounds cells and provides support and structure to tissues. ECM implants are made from a variety of materials, including collagen, fibrin, and hyaluronic acid. Extracellular matrix (ECM) implants provide endogenous stem cells (chondrocytes) both a scaffold on which to grow, and a full complement of extracellular growth signals. This method of cartilage repair relies upon the stimulation of endogenous stem cells to restore damaged or lost cartilage.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Extracellular Matrix Implants pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Extracellular Matrix Implants devices. Overall, most of these Extracellular Matrix Implants pipeline devices are being developed by private entities.
Key players involved in the active development of Extracellular Matrix Implants include Vericel, Anika Therapeutics and Histogen.
For a complete picture of the developmental pipeline for Extracellular Matrix Implants devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.